Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

No reported Selling, General & Admin figures are available to summarize.

Selling, General & Admin history

Currency unavailable · from the income statement

No Selling, General & Admin data reported for this period type.

Selling, General & Admin vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Selling, General & Admin for ODTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALMSAlumis Inc. Common StockLTM Jun 2026$77.08M USD+17.2%+94.2%1041.9%
ANABAnaptysBio, Inc.LTM Mar 2026$62.81M USD+42.2%+11.5%27.0%
SYRESpyre Therapeutics, Inc.LTM Sep 2026$60.45M USD+31.0%+18.9%66.8%
PTGXProtagonist Therapeutics, Inc.LTM Jun 2026$48.49M USD+17.1%+12.2%17.2%
ORKAOruka Therapeutics, Inc.LTM Sep 2026$29.26M USD+41.9%+59.4%—
IMUXImmunic, Inc.LTM Mar 2026$23.53M USD+30.1%+11.7%—
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$22.58M USD+5.5%-4.4%269.8%
AGMBAgomAb Therapeutics N.V. American Depositary SharesFY2024€9.82M EUR+63.8%——
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding ODTX) —+30.5%+12.2%66.8%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.